Provided by Tiger Trade Technology Pte. Ltd.

Regeneron Pharmaceuticals

753.93
-1.5800-0.21%
Pre-market: 752.70-1.2300-0.16%07:01 EDT
Volume:571.28K
Turnover:428.77M
Market Cap:79.71B
PE:18.13
High:760.58
Open:758.67
Low:739.12
Close:755.51
52wk High:821.11
52wk Low:476.49
Shares:105.72M
Float Shares:103.30M
Volume Ratio:0.86
T/O Rate:0.55%
Dividend:3.52
Dividend Rate:0.47%
EPS(TTM):41.59
EPS(LYR):41.48
ROE:14.87%
ROA:5.91%
PB:2.55
PE(LYR):18.18

Loading ...

Regeneron Pharmaceuticals Likely To Report Lower Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Benzinga
·
Jan 30

LIVE MARKETS-Be careful what you Warsh for

Reuters
·
Jan 30

MORNING BID EUROPE-Be careful what you Warsh for

Reuters
·
Jan 30

Regeneron Pharmaceuticals Inc : TD Cowen Raises Target Price to $820 From $800

THOMSON REUTERS
·
Jan 29

Alvotech Sa - Reaches Settlement Agreement With Regeneron and Bayer

THOMSON REUTERS
·
Jan 29

Sanofi vaccine sales face headwinds from US policy shifts

Reuters
·
Jan 29

Regeneron Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Jan 29

Wolfe Adjusts Price Target on Regeneron Pharmaceuticals to $900 From $800, Maintains Outperform Rating

MT Newswires Live
·
Jan 28

Eylea HD Approval And STEM Focus Shape Regeneron’s Growth Outlook

Simply Wall St.
·
Jan 28

Regeneron's Eylea, Dupixent Should Support $625 Valuation Despite Competition, RBC Says

MT Newswires Live
·
Jan 28

Regeneron Pharmaceuticals Inc : Bernstein Raises Target Price to $916 From $911

THOMSON REUTERS
·
Jan 27

Bernstein Adjusts PT on Regeneron Pharmaceuticals to $916 From $911, Maintains Outperform Rating

MT Newswires Live
·
Jan 27

Regeneron Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Jan 27

Rothschild & Co. Redburn Adjusts PT on Regeneron Pharmaceuticals to $940 From $910, Maintains Buy Rating

MT Newswires Live
·
Jan 26

Earning Preview: Regeneron Pharmaceuticals — revenue is expected to increase by 0.52%, and institutional views lean positive

Earnings Agent
·
Jan 23

Regeneron Pharma Is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Jan 22